Research and Development

Partnerships

In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:

Human PrescriptionConsumer Health Care
Animal HealthMergers & Acquisitions


Schering-Plough Biopharma

Located adjacent to Stanford University in the vibrant biotech environment of Silicon Valley, Schering-Plough Biopharma was built by legendary innovators. Combining research strengths in oncology and immunology, there is a legacy of pioneering science at Schering-Plough Biopharma that is being translated into medicines for our future.


 

The IFPMA portal has been designed as a single entry allowing you to search for comprehensive information on on-going clinical trials (registry) or results of completed trials (database) conducted by the innovative pharmaceutical industry.



Pharmaceutical Sciences and Drug Metabolism



The goal of Pharmaceutical Sciences and Drug Metabolism is to deliver a product that fits the needs of the patient.  In Pharmaceutical Sciences, this work starts with a new drug molecule or protein from Discovery, making it in large scale to enable development and commercialization to begin.   The active ingredient is formulated into tablets, capsules and other dosage forms to make available to the patient. Manufacturing processes and analytical methods are developed to make sure the products are consistent, safe and of high quality.  These procedures are used for clinical supply preparation to enable the conduct of clinical regulatory studies. These processes are ultimately transferred to manufacturing to support the launch and production of the new product.  Drug Metabolism similarly begins by characterizing the way the drug is absorbed, broken down and eliminated from the body.  This is especially important during toxicology and clinical trials, where drug levels are monitored to ensure the safety of the patient.  Development concludes with a regulatory dossier describing the preparation and quality of the new product, as well as the fate of the drug in the body.